SEC Filing Update: #TYRA Tyra Biosciences, Inc. : $24.62

Sector: Healthcare | YTD: 🔽 -8.13% The SEC disclosed Today (17-SEP-2026) that RA CAPITAL MANAGEMENT has INCREASED #TYRA Shares by 15.84% 🟢 Paradigm Biocapital Advisors LP also reported an increase in its holdings on the same day. * Previous Holdings: 12.20M Shares * Current Holdings: 14.13M Shares * Increase+1.93M * Increased(%)+15.84% * Ownership: 19.9% * Estimated Investment Value: $47.79M https://www.thinksabio.com/reports/isr/TYRA Institutional ownership in #TYRA has been steadily rising over the past 4 quarters in Shares: Q3 2025: 55.64M Q4 2025: 56.83M Q1 2026: 65.94M Q2 2026: 66.54M 📌 Institutional activity in the last 30 days for #TYRA: • Paradigm Biocapital Advisors LP – Increased holdings by 1,644,846 shares (17-SEP-2026) 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2100693244258418786 RA Capital Management increased its shareholding in Tyra Biosciences from 12,198,625 shares to 14,130,492 shares, representing 19.9% ownership in the healthcare company.